Flumitev 30, 45, 75 30 mg; 45 mg; 75 mg Capsule
PDF Leaflet Revision Date: 10 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment and prophylaxis of influenza.
Dosage (summary)
Adults: 75 mg twice daily for 5 days. Children: Dosing varies by weight.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
- Immunocompromised patients
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; breastfeeding not recommended.
Key Drug Interactions
- Probenecid
- Amoxicillin
- Cimetidine
Contraindications
- Hypersensitivity to oseltamivir or excipients
Common side effects
- Nausea
- Vomiting
- Headache
- Fatigue
Counselling Points
- Monitor for abnormal behavior, especially in children
- Take with food to enhance tolerability
- Complete full course of treatment
Serious warnings
- Neuropsychiatric events reported
- Not a substitute for vaccination
Important Disclaimer
The Flumitev 30, 45, 75 30 mg; 45 mg; 75 mg Capsule professional information leaflet below is the property of Teva Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
